Cheap Chinese Antibiotics Threaten Europe's Last Major Penicillin Plant
Oct 21, 2026
Sandoz's last integrated European penicillin plant faces closure due to low-cost Chinese competition, prompting an EU anti-dumping investigation. The situation highlights critical supply chain vulnerabilities and strategic risks in the global pharmaceutical ingredient market.